Long-term Antipsychotic Treatment and Brain Volumes: A Longitudinal Study of First-Episode Schizophrenia
TLDR
It is suggested that antipsychotics have a subtle but measurable influence on brain tissue loss over time, suggesting the importance of careful risk-benefit review of dosage and duration of treatment as well as their off-label use.Abstract:
Context Progressive brain volume changes in schizophrenia are thought to be due principally to the disease. However, recent animal studies indicate that antipsychotics, the mainstay of treatment for schizophrenia patients, may also contribute to brain tissue volume decrement. Because antipsychotics are prescribed for long periods for schizophrenia patients and have increasingly widespread use in other psychiatric disorders, it is imperative to determine their long-term effects on the human brain. Objective To evaluate relative contributions of 4 potential predictors (illness duration, antipsychotic treatment, illness severity, and substance abuse) of brain volume change. Design Predictors of brain volume changes were assessed prospectively based on multiple informants. Setting Data from the Iowa Longitudinal Study. Patients Two hundred eleven patients with schizophrenia who underwent repeated neuroimaging beginning soon after illness onset, yielding a total of 674 high-resolution magnetic resonance scans. On average, each patient had 3 scans (≥2 and as many as 5) over 7.2 years (up to 14 years). Main Outcome Measure Brain volumes. Results During longitudinal follow-up, antipsychotic treatment reflected national prescribing practices in 1991 through 2009. Longer follow-up correlated with smaller brain tissue volumes and larger cerebrospinal fluid volumes. Greater intensity of antipsychotic treatment was associated with indicators of generalized and specific brain tissue reduction after controlling for effects of the other 3 predictors. More antipsychotic treatment was associated with smaller gray matter volumes. Progressive decrement in white matter volume was most evident among patients who received more antipsychotic treatment. Illness severity had relatively modest correlations with tissue volume reduction, and alcohol/illicit drug misuse had no significant associations when effects of the other variables were adjusted. Conclusions Viewed together with data from animal studies, our study suggests that antipsychotics have a subtle but measurable influence on brain tissue loss over time, suggesting the importance of careful risk-benefit review of dosage and duration of treatment as well as their off-label use.read more
Citations
More filters
Journal ArticleDOI
The Psychosis High-Risk State: A Comprehensive State-of-the-Art Review
Paolo Fusar-Poli,Stefan Borgwardt,Andreas Bechdolf,Jean Addington,Anita Riecher-Rössler,Frauke Schultze-Lutter,Matcheri S. Keshavan,Stephen J. Wood,Stephan Ruhrmann,Larry J. Seidman,Lucia Valmaggia,Tyrone D. Cannon,Eva Velthorst,Lieuwe de Haan,Barbara A. Cornblatt,Ilaria Bonoldi,Max Birchwood,Thomas H. McGlashan,William T. Carpenter,Patrick D. McGorry,Joachim Klosterkötter,Philip McGuire,Alison R. Yung +22 more
TL;DR: The relatively new field of HR research in psychosis has the potential to shed light on the development of major psychotic disorders and to alter their course and provides a rationale for service provision to those in need of help who could not previously access it.
Journal ArticleDOI
Predicting Psychosis: Meta-analysis of Transition Outcomes in Individuals at High Clinical Risk
Paolo Fusar-Poli,Ilaria Bonoldi,Alison R. Yung,Stefan Borgwardt,Matthew J. Kempton,Lucia Valmaggia,Francesco Barale,Edgardo Caverzasi,Philip McGuire +8 more
TL;DR: The state of clinical high risk is associated with a very high risk of developing psychosis within the first 3 years of clinical presentation, and the risk progressively increases across this period.
Journal ArticleDOI
Identification of a common neurobiological substrate for mental illness.
Madeleine S. Goodkind,Simon B. Eickhoff,Desmond J. Oathes,Desmond J. Oathes,Ying Jiang,Ying Jiang,Andrew Chang,Andrew Chang,Laura B. Jones-Hagata,Laura B. Jones-Hagata,Brissa N. Ortega,Brissa N. Ortega,Yevgeniya V. Zaiko,Yevgeniya V. Zaiko,Erika L. Roach,Erika L. Roach,Mayuresh S. Korgaonkar,Stuart M. Grieve,Isaac R. Galatzer-Levy,Peter T. Fox,Amit Etkin,Amit Etkin +21 more
TL;DR: A concordance is identified in terms of integrity of an anterior insula/dorsal anterior cingulate-based network, which may relate to executive function deficits observed across diagnoses, which provides an organizing model that emphasizes the importance of shared neural substrates across psychopathology.
Journal ArticleDOI
Subcortical brain volume abnormalities in 2028 individuals with schizophrenia and 2540 healthy controls via the ENIGMA consortium
T.G.M. van Erp,Derrek P. Hibar,Jerod M. Rasmussen,David C. Glahn,Godfrey D. Pearlson,Ole A. Andreassen,Ingrid Agartz,Ingrid Agartz,Lars T. Westlye,Lars T. Westlye,Unn K. Haukvik,Anders M. Dale,Ingrid Melle,Cecilie B. Hartberg,Oliver Gruber,Bernd Kraemer,David Zilles,Gary Donohoe,Gary Donohoe,Sinead Kelly,Sinead Kelly,Colm McDonald,Derek W. Morris,Derek W. Morris,Dara M. Cannon,Aiden Corvin,Marise W. J. Machielsen,Laura Koenders,L. de Haan,Dick J. Veltman,Theodore D. Satterthwaite,Daniel H. Wolf,R.C. Gur,R.E. Gur,Steven G. Potkin,Daniel H. Mathalon,Daniel H. Mathalon,Bryon A. Mueller,Adrian Preda,Fabio Macciardi,Stefan Ehrlich,Stefan Ehrlich,Esther Walton,Johanna Hass,Vince D. Calhoun,HJ Bockholt,Scott R. Sponheim,Jody M. Shoemaker,N.E.M. van Haren,Hilleke E. Hulshoff Pol,Roel A. Ophoff,Roel A. Ophoff,René S. Kahn,Roberto Roiz-Santiañez,Benedicto Crespo-Facorro,Lei Wang,Kathryn I. Alpert,Erik G. Jönsson,Erik G. Jönsson,Rali Dimitrova,Catherine Bois,Heather C. Whalley,Andrew M. McIntosh,Stephen M. Lawrie,Ryota Hashimoto,Paul M. Thompson,Jessica A. Turner +66 more
TL;DR: Worldwide cooperative analyses of brain imaging data support a profile of subcortical abnormalities in schizophrenia, which is consistent with that based on traditional meta-analytic approaches, and validates that collaborative data analyses can readily be used across brain phenotypes and disorders.
Journal ArticleDOI
Schizophrenia: an integrated sociodevelopmental-cognitive model
TL;DR: It is shown that developmental alterations secondary to variant genes, early hazards to the brain, and childhood adversity sensitise the dopamine system, and result in excessive presynaptic dopamine synthesis and release.
References
More filters
Journal ArticleDOI
The effects of antipsychotics on brain structure: what have we learnt from structural imaging of schizophrenia?
TL;DR: This article found that patients with schizophrenia receiving treatment with antipsychotics had reduced grey matter (GM) volume, particularly in frontal and temporal lobes, and increased volume of the basal ganglia.